3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
3
Withdrawn
1
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasms
38
Breast Neoplasms
31
Lung Neoplasms
25
Colorectal Neoplasms
15
Prostatic Neoplasms
13
Pancreatic Neoplasms
11
Ovarian Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Head and Neck Neoplasms
9
Sarcoma
8
Colonic Neoplasms
8
Carcinoma, Hepatocellular
8
Uterine Cervical Neoplasms
7
Glioma
7
Esophageal Neoplasms
7
Melanoma
6
Lymphoma
6
Endometrial Neoplasms
6
Neoplastic Cells, Circulating
5
Multiple Myeloma
5
Brain Neoplasms
5
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Neoplasm, Residual
4
Gastrointestinal Neoplasms
4
Carcinoma, Squamous Cell
4
Carcinoma, Renal Cell
4
Adenocarcinoma
4
Thrombosis
3
Rectal Neoplasms
3
Interventions
pembrolizumab
57
Carboplatin
34
Paclitaxel
24
Cyclophosphamide
23
Capecitabine
18
sacituzumab govitecan
16
Specimen Handling
15
130-nm albumin-bound paclitaxel
15
toripalimab
11
Drug Therapy
11
Biopsy
11
Magnetic Resonance Spectroscopy
10
Bevacizumab
10
Taxes
9
Epirubicin
9
durvalumab
8
Albumin-Bound Paclitaxel
8
olaparib
7
camrelizumab
7
Gemcitabine
7
Doxorubicin
7
Docetaxel
7
fludarabine
6
famitinib
5
Nivolumab
5
Injections
5
atezolizumab
4
abemaciclib
4
Trastuzumab
4
Standard of Care
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Triple Negative Breast Neoplasms
×
Blood Specimen Collection
×
Clear all
NCT07260188
2025-12-03
PDO-Neo01
Istituti Clinici Scientifici Maugeri SpA
Recruiting
240 enrolled